BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 18774239)

  • 1. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of methadone treatment on cardiac repolarization and conduction in opioid users.
    Martell BA; Arnsten JH; Krantz MJ; Gourevitch MN
    Am J Cardiol; 2005 Apr; 95(7):915-8. PubMed ID: 15781034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onsite QTc interval screening for patients in methadone maintenance treatment.
    Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
    J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic abnormalities in opiate addicts.
    Wallner C; Stöllberger C; Hlavin A; Finsterer J; Hager I; Hermann P
    Addiction; 2008 Dec; 103(12):1987-93. PubMed ID: 19469742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
    Krook AL; Waal H; Hansteen V
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc interval prolongation in patients on long-term methadone maintenance therapy.
    Maremmani I; Pacini M; Cesaroni C; Lovrecic M; Perugi G; Tagliamonte A
    Eur Addict Res; 2005; 11(1):44-9. PubMed ID: 15608471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone.
    Skjervold B; Bathen J; Spigset O
    J Clin Psychopharmacol; 2006 Dec; 26(6):687-9. PubMed ID: 17110841
    [No Abstract]   [Full Text] [Related]  

  • 15. QTc prolongation among hospitalized patients receiving methadone.
    Schmittner J; Krantz MJ
    Arch Intern Med; 2006 Nov; 166(20):2289; author reply 2289-90. PubMed ID: 17101954
    [No Abstract]   [Full Text] [Related]  

  • 16. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of QTc in patients receiving chronic methadone therapy.
    Cruciani RA; Sekine R; Homel P; Lussier D; Yap Y; Suzuki Y; Schweitzer P; Yancovitz SR; Lapin JA; Shaiova L; Sheu RG; Portenoy RK
    J Pain Symptom Manage; 2005 Apr; 29(4):385-91. PubMed ID: 15857742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.